L&C BIO Co.,LTD (KOSDAQ:290650)

L&C BIO Co.,LTD Statistics

Total Valuation

L&C BIO Co.,LTD has a market cap or net worth of KRW 450.30 billion. The enterprise value is 560.43 billion.

Market Cap	450.30B
Enterprise Value	560.43B

Important Dates

The last earnings date was Monday, March 17, 2025.

Earnings Date	Mar 17, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

L&C BIO Co.,LTD has 22.68 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	22.68M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	29.90%
Owned by Institutions (%)	15.03%
Float	15.32M

Valuation Ratios

The trailing PE ratio is 3.45.

PE Ratio	3.45
Forward PE	n/a
PS Ratio	6.25
PB Ratio	1.58
P/TBV Ratio	5.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 60.29, with an EV/FCF ratio of -42.19.

EV / Earnings	3.97
EV / Sales	7.77
EV / EBITDA	60.29
EV / EBIT	220.46
EV / FCF	-42.19

Financial Position

The company has a current ratio of 0.84, with a Debt / Equity ratio of 0.42.

Current Ratio	0.84
Quick Ratio	0.49
Debt / Equity	0.42
Debt / EBITDA	13.33
Debt / FCF	-9.33
Interest Coverage	0.79

Financial Efficiency

Return on equity (ROE) is 63.44% and return on invested capital (ROIC) is 0.48%.

Return on Equity (ROE)	63.44%
Return on Assets (ROA)	0.43%
Return on Invested Capital (ROIC)	0.48%
Return on Capital Employed (ROCE)	0.79%
Revenue Per Employee	554.56M
Profits Per Employee	1.09B
Employee Count	130
Asset Turnover	0.20
Inventory Turnover	0.78

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.45% in the last 52 weeks. The beta is 0.60, so L&C BIO Co.,LTD's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	-12.45%
50-Day Moving Average	22,555.00
200-Day Moving Average	20,599.75
Relative Strength Index (RSI)	35.99
Average Volume (20 Days)	99,695

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, L&C BIO Co.,LTD had revenue of KRW 72.09 billion and earned 141.06 billion in profits. Earnings per share was 5,663.00.

Revenue	72.09B
Gross Profit	35.73B
Operating Income	2.54B
Pretax Income	137.79B
Net Income	141.06B
EBITDA	9.30B
EBIT	2.54B
Earnings Per Share (EPS)	5,663.00

Balance Sheet

The company has 24.14 billion in cash and 123.90 billion in debt, giving a net cash position of -99.76 billion or -4,397.77 per share.

Cash & Cash Equivalents	24.14B
Total Debt	123.90B
Net Cash	-99.76B
Net Cash Per Share	-4,397.77
Equity (Book Value)	294.73B
Book Value Per Share	12,529.41
Working Capital	-24.49B

Cash Flow

In the last 12 months, operating cash flow was -8.57 billion and capital expenditures -4.72 billion, giving a free cash flow of -13.28 billion.

Operating Cash Flow	-8.57B
Capital Expenditures	-4.72B
Free Cash Flow	-13.28B
FCF Per Share	-585.50

Margins

Gross margin is 49.56%, with operating and profit margins of 3.53% and 195.67%.

Gross Margin	49.56%
Operating Margin	3.53%
Pretax Margin	191.13%
Profit Margin	195.67%
EBITDA Margin	12.89%
EBIT Margin	3.53%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.25%.

Dividend Per Share	50.00
Dividend Yield	0.25%
Dividend Growth (YoY)	-50.00%
Years of Dividend Growth	n/a
Payout Ratio	1.61%
Buyback Yield	n/a
Shareholder Yield	0.25%
Earnings Yield	31.33%
FCF Yield	-2.95%

Stock Splits

The last stock split was on October 12, 2020. It was a forward split with a ratio of 3.

Last Split Date	Oct 12, 2020
Split Type	Forward
Split Ratio	3

Scores

L&C BIO Co.,LTD has an Altman Z-Score of 2.35. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.35
Piotroski F-Score	n/a